Germline BRIP1 mutations, which negatively affect DNA repair and genomic stability, and thus increase the likelihood of cancer development, have been reported to be connected with breast, colon, prostate and ovarian cancer [4,8,12,13]. Here, BRIP1 is linked to ovarian cancer.